Among GC cases with well differentiated disease only 21.9% (14/66) were having PDL1 mRNA overexpression compared to GC patients with poorly differentiated disease among which 69.2% (27/37) were having PDL1 overexpression (OR = 8.1; p = 0.00). The gene discussed is CD274; the disease is gastric cancer.